Takara Bio Inc.'s market cap is currently ¥112.95B. The company's EPS TTM is ¥-12.55; its P/E ratio is 195.76; and it has a dividend yield of 1.82%. Takara Bio Inc. is scheduled to report earnings on August 8, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
